Skip to content

PAR PHARMACEUTICAL COMPANIES, INC.

Delisted

CIK 878088fmd_08MCHY5S1HN0WFT8V3WXR0N0PTManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Jun 30, 2015, 21 periods

Latest annual · FY2011

Millions
Total revenues
926
Gross profit
387
Operating income
(51)
Net income
(106)
Free cash flow
53

Latest quarter · Q2 FY2015

Millions
Total revenues
332
Gross profit
140
Operating income
46
Net income
5
Free cash flow
(10)
Open Financials

PAR PHARMACEUTICAL COMPANIES, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2013FY2011ChangeSource
Net income-$105.9 million-$26.1 million10-K 2014-03-18 · proof
Total assets$2.6 billion$1.2 billion+114.2%10-K 2015-03-13 · proof
Total liabilities$2.1 billion$621.9 million+236%10-K 2015-03-13 · proof
Cash and cash equivalents$130.1 million$162.5 million-20%10-K 2014-03-18 · proof
Total debt$1.5 billion$345.6 million+344.9%10-K 2014-03-18 · proof
What was PAR PHARMACEUTICAL COMPANIES, INC.'s net income in fiscal 2013?
PAR PHARMACEUTICAL COMPANIES, INC. reported net income of -$105.9 million for fiscal 2013 (the year ended Dec 31, 2013), against -$26.1 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2014. SEC
What are PAR PHARMACEUTICAL COMPANIES, INC.'s total assets?
As of Dec 31, 2013, PAR PHARMACEUTICAL COMPANIES, INC. reported total assets of $2.6 billion, against $1.2 billion a year earlier (+114.2%). Source: the 10-K filed with the SEC on Mar 13, 2015 (restated). SEC
What are PAR PHARMACEUTICAL COMPANIES, INC.'s total liabilities?
As of Dec 31, 2013, PAR PHARMACEUTICAL COMPANIES, INC. reported total liabilities of $2.1 billion, against $621.9 million a year earlier (+236%). Source: the 10-K filed with the SEC on Mar 13, 2015 (restated). SEC
What are PAR PHARMACEUTICAL COMPANIES, INC.'s cash and cash equivalents?
As of Dec 31, 2013, PAR PHARMACEUTICAL COMPANIES, INC. reported cash and cash equivalents of $130.1 million, against $162.5 million a year earlier (-20%). Source: the 10-K filed with the SEC on Mar 18, 2014. SEC
What is PAR PHARMACEUTICAL COMPANIES, INC.'s total debt?
As of Dec 31, 2013, PAR PHARMACEUTICAL COMPANIES, INC. reported total debt of $1.5 billion, against $345.6 million a year earlier (+344.9%). Source: the 10-K filed with the SEC on Mar 18, 2014. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:878088&period_type=annual&limit=5"

Information only, not investment advice.